Position in NBIX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,097,979
-$1,627,783 QoQ
Shares Held
46,288
-15.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 84.11467334946423.ToString("F0")%
Shared 0.ToString("F0")%
None 15.885326650535776.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Boston Partners holds $43,936,854 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (13.9% of the industry book) .
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,097,979 | 46,288 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $7,725,762 | 54,472 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||